EDEM3 and neoplasm: In addition, EDEM3 overexpression in CT26 tumour cells did not significantly inhibit tumour growth in the presence of the PD‐L1 antibody treatment (Figure 7A–D and Figure S12A,B), likely because the basal PD‐L1 expression was already high (Figure 3I).